Subuphine 2 mg Resoriblett, sublingual

País: Suécia

Língua: sueco

Origem: Läkemedelsverket (Medical Products Agency)

Ingredientes ativos:

buprenorfinhydroklorid

Disponível em:

Activase Pharmaceuticals Limited

Código ATC:

N07BC01

DCI (Denominação Comum Internacional):

buprenorphine hydrochloride

Dosagem:

2 mg

Forma farmacêutica:

Resoriblett, sublingual

Composição:

mannitol Hjälpämne; buprenorfinhydroklorid 2,16 mg Aktiv substans; laktosmonohydrat Hjälpämne

Classe:

Apotek

Tipo de prescrição:

Receptbelagt

Área terapêutica:

Buprenorfin

Resumo do produto:

Förpacknings: Blister, 7 tabletter; Blister, 14 tabletter; Blister, 28 tabletter

Status de autorização:

Godkänd

Data de autorização:

2010-07-02

Folheto informativo - Bula

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
SUBUPHINE 0.4, 2 AND 8 MG SUBLINGUAL TABLETS
buprenorphine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Subuphine is and what it is used for
2.
What you need to know before you take Subuphine
3.
How to take Subuphine
4.
Possible side effects
5.
How to store Subuphine
6.
Contents of the pack and other information.
1.
WHAT SUBUPHINE IS AND WHAT IT IS USED FOR
Subuphine is a medicinal product used in opioid (narcotic) dependence.
Subuphine are used as part of a medical, social and psychological
treatment programme for patients addicted
to opiate (narcotic) drugs.
Treatment is prescribed and monitored by physicians who are
specialists in the treatment of drug
dependence.
Treatment with Subuphine is intended for use in adults and adolescents
over 15 years of age.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE SUBUPHINE
DO NOT TAKE
SUBUPHINE IF YOU:

are allergic to buprenorphine or any of the other ingredients of this
medicine (listed in section 6)

suffer from serious breathing difficulties

suffer from a seriously reduced liver function

suffer from alcoholism or delirium tremens (the “shakes” and
hallucinations)
WARNINGS AND PRECAUTIONS:
Talk to your doctor or pharmacist before taking Subuphine.
Tell your doctor if you have any of the following illnesses before
treatment or develop them during
treatment, as your doctor may need to reduce your dose of Subuphine or
you may need extra treatment to
control them:

have taken morphine o
                                
                                Leia o documento completo
                                
                            

Características técnicas

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Leia o documento completo
                                
                            

Documentos em outros idiomas

Folheto informativo - Bula Folheto informativo - Bula inglês 16-07-2021
Características técnicas Características técnicas inglês 18-10-2017